Platinum-based chemotherapy (first-line regimen)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum-based chemotherapy (first-line regimen), covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer [Phase 3]